Results 101 to 110 of about 8,233 (133)

CD8+ T-cell Antitumor Immunity via Human iNKT-DC Conjugates. [PDF]

Cancer Immunol Res
Baiu DC, Smith KA, Ferguson SA, Schwartz NR, Tripathy S, Brand J, Dinh HQ, Ohashi M, Johannsen EC, Gumperz JE.   +9 more
europepmc   +1 more source

Innate-like T Cell Biology in the Tumor Microenvironment Implications for Cancer Immunotherapy. [PDF]

Cells
Sanjari Pour M, Nasimian A, Kazi JU.
europepmc   +1 more source

<i>In vivo</i> stimulation of natural killer T cells and downstream regulatory T cells to reduce acute graft-versus-host disease. [PDF]

Ann Transl Med
Sluyter R, McErlean G.
europepmc   +1 more source

A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol. [PDF]

PLoS One
Kurokawa T, Iinuma T, Ebisu H, Yanagidaira T, Inaba Y, Fujiwara T, Hattori Y, Fukazawa T, Aoki T, Koseki H, Hanaoka H, Hanazawa T, Motohashi S.   +12 more
europepmc   +1 more source

Artificial thymic organoid culture generates functional iPSC-derived CD4+ invariant natural killer T cells. [PDF]

Commun Biol
Shiina S, Ueda T, Iriguchi S, Uemura Y, Kaneko S.   +4 more
europepmc   +1 more source

Preoperative malnutrition is associated with suppressed intratumoral T cell function and distinct tumor-associated microbiota in colorectal cancer: a prospective pilot study. [PDF]

Front Nutr
Perillo F, Mascaretti F, Maragno P, Amoroso C, Oriani E, Baeri A, Pinco P, Pozzi L, Baldari L, Caprioli F, Ghidini M, Strati F, Facciotti F.   +12 more
europepmc   +1 more source

Functional remodeling of iNKT cells by sulfatide-reactive type II NKT cells reprograms alveolar macrophages to alleviate lung ischemia-reperfusion injury. [PDF]

Commun Biol
Li Q, Yin J, Lin Q, Xu Y, He J, Shi X, Huang S, Wang Y, Huang Y, Ding X, Yu H, Nie H.   +11 more
europepmc   +1 more source

The Role of the T Cell Receptor Sequence in Shaping T Cell Functional Fate. [PDF]

Immunol Rev
Mantena S, Raychaudhuri S.
europepmc   +1 more source

Editorial: Community series in the role of CD1- and MR1-restricted T cells in immunity and disease: volume III. [PDF]

Front Immunol
Iwabuchi K, Van Kaer L.
europepmc   +1 more source